500,000 people worldwide are diagnosed with head and neck cancers every year,” says Cary Rentner, president of CancerPlans.com. “Here at Cancerplans.com, we provide supplemental insurance that helps cancer patients pay for the treatments they need.
Fort Lauderdale, Florida (PRWEB) August 07, 2012
CancerPlans.com announced the release of an important new study on the benefits of TORS (trans-oral robotic surgery) for patients with head and neck cancers. Mount Sinai School of Medicine presented their findings on TORS at the Eighth International Conference on Head and Neck Cancer, held in Toronto from July 21-25. According to Mount Sinai researchers, trans-oral robotic surgery showed significant promise in treating smokers with acute head and neck cancer.
Transoral robotic surgery is a minimally invasive surgical procedure that accesses the surgical site via the mouth. TORS removes tumors of the mouth, throat, tonsils, tongue and voice box without making major incisions or interfering with swallowing or speech.
The study used TORS to treat 35 smokers and 22 nonsmokers, evaluating their progress 19.9 months after surgery. At the check point, progression-free survival for the smokers was 91 percent, while progression-free survival for the non-smokers was 96 percent. 100% of the non-smoking patients and 97% of the smokers remained alive. In addition, 94% and 96% of tumors removed with TORS did not reappear, while robotic surgery prevented metastasis in 97% and 100% of patients, respectively.
"The prognosis for smokers who are diagnosed with head and neck cancer has historically been poor," says Mount Sinai School of Medicine Chief Resident Chaz L. Stucken, MD. "However, our analysis shows that robotic surgery is highly effective in treating these patients and should be considered as a primary treatment modality in this patient population."
CancerPlans.com expressed their approval for continuing research into trans-oral robotic surgery.
“500,000 people worldwide are diagnosed with head and neck cancers every year,” says Cary Rentner, president of CancerPlans.com. “Here at Cancerplans.com, we provide supplemental insurance that helps cancer patients pay for the treatments they need.”
Cancer insurance is a supplemental insurance policy that provides a lump sum benefit upon first diagnosis of cancer. Patients can use cancer insurance benefit money to pay for cutting-edge treatments like robotic surgery, as well as for alternative medicine, deductibles, co-pays, or living expenses. As a stand-alone policy, cancer insurance does not require any type of prior health insurance.
About Mount Sinai School of Medicine: Mount Sinai is a leader in biomedical research, patient care, and medical and scientific training. Partnering with Mount Sinai Hospital, Mount Sinai School of Medicine draws on the expertise of a world-class medical staff to serve a diverse group of patients and students.
About CancerPlans.com: As an independent, nationally licensed insurance agency, CancerPlans.com provides information about supplemental insurance policies, allowing customers to find the best cancer or critical illness insurance provider for their needs. The site’s proprietary technology allows customers to process application forms and communicate with insurance providers in a single online process. Visitors can quote, compare and apply for cancer insurance in one place on CancerPlans.com.
4495 SW 67th Terrace, Suite #206
Fort Lauderdale, FL 33314
Ph: + 1-888-55-CRITICAL